1. Adverse outcome of AML with aberrant CD16 and CD56 NK cell marker expression. Issue 3 (3rd June 2018) Authors: Junge, Alexandra; Bacher, Ulrike; Mueller, Beatrice U.; Keller, Peter; Solenthaler, Max; Pabst, Thomas Journal: Hematological oncology Issue: Volume 36:Issue 3(2018) Page Start: 576 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CD34+ selected versus unselected autologous stem cell transplantation in patients with advanced-stage mantle cell and diffuse large B-cell lymphoma. Issue 6 (June 2015) Authors: Berger, Martin D.; Branger, Giacomo; Leibundgut, Kurt; Baerlocher, Gabriela M.; Seipel, Katja; Mueller, Beatrice U.; Gregor, Michael; Ruefer, Axel; Pabst, Thomas Journal: Leukemia research Issue: Volume 39:Issue 6(2015:Jun.) Page Start: 561 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Consolidation of first remission using radioimmunotherapy with yttrium-90-ibritumomab-tiuxetan in adult patients with Burkitt lymphoma. Issue 3 (March 2015) Authors: Koechli, Valentin; Klaeser, Bernd; Banz, Yara; Mueller, Beatrice U.; Pabst, Thomas Journal: Leukemia research Issue: Volume 39:Issue 3(2015:Mar.) Page Start: 307 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Delayed Haematological recovery after autologous stem cell transplantation is associated with favourable outcome in acute myeloid leukaemia. (12th September 2014) Authors: Wetzel, Dana; Mueller, Beatrice U.; Mansouri Taleghani, Behrouz; Baerlocher, Gabriela M.; Seipel, Katja; Leibundgut, Kurt; Pabst, Thomas Journal: British journal of haematology Issue: Volume 168:Number 2(2015:Jan.) Page Start: 268 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Improved survival rates of AML patients following admission to the intensive care unit. Issue 10 (24th August 2019) Authors: Fassbind, Priska; Jeker, Barbara; Mueller, Beatrice U.; Bacher, Ulrike; Zimmerli, Stefan; Endrich, Olga; Gahl, Brigitta; Novak, Urban; Pabst, Thomas Journal: Leukemia & lymphoma Issue: Volume 60:Issue 10(2019) Page Start: 2423 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Iron overload is correlated with impaired autologous stem cell mobilization and survival in acute myeloid leukemia. Issue 10 (10th September 2018) Authors: Alva, Laura C.; Bacher, Ulrike; Seipel, Katja; Mansouri Taleghani, Behrouz; Mueller, Beatrice U.; Novak, Urban; Pabst, Thomas Journal: Transfusion Issue: Volume 58:Issue 10(2018) Page Start: 2365 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Neurotoxicity of stem cell mobilization chemotherapy with vinorelbine in myeloma patients after bortezomib treatment. Issue 7 (July 2015) Authors: Keller, Sandra; Seipel, Katja; Novak, Urban; Mueller, Beatrice U.; Taleghani, Behrouz Mansouri; Leibundgut, Kurt; Pabst, Thomas Journal: Leukemia research Issue: Volume 39:Issue 7(2015:Jul.) Page Start: 786 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Rebound Thrombocytosis after Induction Chemotherapy is a Strong Biomarker for Favorable Outcome in AML Patients. Issue 2 (April 2019) Authors: Schnell, Bianca R.; Seipel, Katja; Bacher, Ulrike; Jeker, Barbara; Mueller, Beatrice U.; Banz, Yara; Novak, Urban; Pabst, Thomas Journal: HemaSphere Issue: Volume 3:Issue 2(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Role of plerixafor in autologous stem cell mobilization with vinorelbine chemotherapy and granulocyte-colony stimulating factor in patients with myeloma: a phase II study (PAV-trial). Issue 3 (March 2015) Authors: Schmid, Andrea; Friess, Dorothea; Mansouri Taleghani, Behrouz; Keller, Peter; Mueller, Beatrice U.; Baerlocher, Gabriela M.; Leibundgut, Kurt; Pabst, Thomas Journal: Leukemia & lymphoma Issue: Volume 56:Issue 3(2015:Mar.) Page Start: 608 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Stem cell mobilization chemotherapy with gemcitabine is effective and safe in myeloma patients with bortezomib-induced neurotoxicity. Issue 5 (3rd May 2016) Authors: Mueller, Beatrice U.; Keller, Sandra; Seipel, Katja; Mansouri Taleghani, Behrouz; Rauch, Daniel; Betticher, Daniel; Egger, Thomas; Pabst, Thomas Journal: Leukemia & lymphoma Issue: Volume 57:Issue 5(2016:May) Page Start: 1122 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗